Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

PTC Inc. - Common Stock (NQ: PTC )

187.10 +1.85 (+1.00%)
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about PTC Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
This Software Stock Could Be the Best Investment of the Decade
Via The Motley Fool
Demystifying PTC: Insights From 7 Analyst Reviews
Via Benzinga
PTC (PTC): Buy, Sell, or Hold Post Q3 Earnings?
PTC trades at $199 per share and has stayed right on track with the overall market, gaining 15.2% over the last six months. At the same time, the S&P 500 has returned 10.6%. 
Via StockStory
Topics Stocks
Exposures US Equities
$1000 Invested In PTC 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Unity Software Stock Gets Relative Strength Rating Lift
The Relative Strength (RS) Rating for Unity Software stock moved into a higher percentile Monday, as it got a lift from 67 to 75. 
Via Investor's Business Daily
Peering Into PTC's Recent Short Interest
Via Benzinga
6 Analysts Assess PTC: What You Need To Know
Via Benzinga
An Overview of PTC's Earnings
Via Benzinga
Here's How Much You Would Have Made Owning PTC Stock In The Last 10 Years
Via Benzinga
Critical Insights From PTC Analyst Ratings: What You Need To Know
Via Benzinga
Q3 Rundown: Autodesk (NASDAQ:ADSK) Vs Other Design Software Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how design software stocks fared in Q3, starting with Autodesk... 
Via StockStory
Unpacking Q3 Earnings: Procore (NYSE:PCOR) In The Context Of Other Design Software Stocks
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the design software industry, including Procore (NYSE:PCOR) and its peers. 
Via StockStory
A Few Years From Now, You'll Wish You'd Bought This Undervalued Stock
Via The Motley Fool
Design Software Stocks Q3 Recap: Benchmarking Adobe (NASDAQ:ADBE)
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the design software stocks, including Adobe (NASDAQ:ADBE) and its peers. 
Via StockStory
A Look Back at Design Software Stocks’ Q3 Earnings: PTC (NASDAQ:PTC) Vs The Rest Of The Pack
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the design software stocks, including PTC (NASDAQ:PTC) and its peers. 
Via StockStory
Here's How Much $100 Invested In PTC 10 Years Ago Would Be Worth Today
Via Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $500 Today
Via Benzinga
Unpacking Q3 Earnings: Cadence (NASDAQ:CDNS) In The Context Of Other Design Software Stocks
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the design software industry, including Cadence (NASDAQ:CDNS) and its peers. 
Via StockStory
PTC (PTC) Q4 2024 Earnings Call Transcript
PTC earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
PTC’s (NASDAQ:PTC) Q3 Sales Beat Estimates, Growth To Accelerate Next Year
Engineering and design software provider PTC (NASDAQ:PTC) met Wall Street’s revenue expectations in Q3 CY2024, with sales up 14.6% year on year to $626.5 million. On the other hand, next quarter’s... 
Via StockStory
Topics Earnings
Exposures Financial
What To Expect From PTC’s (PTC) Q3 Earnings
Engineering and design software provider PTC (NASDAQ:PTC) will be reporting results tomorrow afternoon. Here’s what to look for. 
Via StockStory
$100 Invested In PTC 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Here's How Much $1000 Invested In PTC 10 Years Ago Would Be Worth Today
Via Benzinga
Here's How Much You Would Have Made Owning PTC Stock In The Last 10 Years
Via Benzinga
Larimar Therapeutics' New Drug Could Transform Treatment For Rare Neurological Disease, Analyst Sees Over 200% Upside For Stock
Oppenheimer has initiated coverage on Larimar Therapeutics, emphasizing its lead program Nomlabofusp as a transformative therapy for Friedreich's ataxia. With a price target of $26, the company plans... 
Via Benzinga
Exposures Product Safety
2 Stocks Down 66% and 8% to Buy Right Now
Looking for explosive stocks? These companies have what it takes to crush the market. 
Via The Motley Fool
Get Your Money Out of These 3 Robotics Stocks by 2025
Robotics and artificial intelligence can go hand-in-hand, but these robotics stocks to sell are not worth the hype. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
1 Magnificent Software Stock Down 10% to Buy and Hold Forever
This industrial software company continues to grow its key metric and cash flow. 
Via The Motley Fool
The 3 Best Augmented Reality Stocks to Buy in August 2024
These augmented reality stocks are positioned to provide significant returns to long-term investors due to their high growth potential. 
Via InvestorPlace
3 Best Vanguard Stock ETFs to Buy in August
These Vanguard funds could benefit from two key tailwinds this month. 
Via The Motley Fool
Topics ETFs
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.